the Inhalation Focus Group of the Academy of Pharmaceutical Sciences and the RSC Formulation Science and Technology Group
Thursday 15 October 2009
at the Royal Pharmaceutical Society, London
The development and manufacture of inhaled products presents significant technical and regulatory challenges, in which the generation and interpretation of analytical data plays a key role.
This one-day seminar examined the current state of the art and future directions in the analysis of inhaled products, drawing on the experience of industry-regulator working groups and academic groups.
